The Food and Drug Administration has approved the use of remdesivir for all patients hospitalized with COVID-19, despite the lack of published scientific support. Meanwhile, the FDA has ousted its top spokeswoman and a PR consultant just days after FDA Commissioner Stephen Hahn apologized for overstating the positive results of using blood plasma as a treatment for COVID-19. Under enormous pressure from President Trump, who called the FDA part of the “deep state,” the FDA recently gave emergency use authorization for the plasma treatment. The FDA chief is now admitting the agency may also consider emergency use approval for a COVID-19 vaccine before Phase 3 trials are complete.